Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia by Aysun Seker, Nurdan Senturk Durmus

Subjects: Get full text

Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus by Rachida Aouameur, Hafida Bendaoud, Ouafa Guellati, Amel Dammene-Debbih, Manar Lahmar, Nacera Benmouhoub, Zahra Farah, Hichem Makhloufi, Issam Frigaa, Fadela Madaci, Lamine Mahi

Subjects: Get full text

Efficacy and safety of intravenous ferric carboxymaltose in the treatment of Restless Legs Syndrome: a systematic review and meta-analysis by Ayesha Khan, Harsh Kumar, Kuldeep Dalpat Rai, Anzel Saeed, Jawad Ishtiaq, Muhammad Tanveer Alam, Sakshi Chawla, Md Ariful Haque, Md Ariful Haque

Subjects: Get full text

The experiences of ferric carboxymaltose desensitization and provocation by Fatma Dindar Çelik, MD, Kurtuluş Aksu, MD, Özgür Akkale, MD, Hatice Çelik Tuğlu, MD, Melis Yağdıran, MD, Onur Telli, MD, Gürgün Tuğçe Vural Solak, MD, Enes Çelik, MD

Subjects: Get full text